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During cardiogenesis, a subset of epicardial cells undergoes epithelial–mesenchymal-transition (EMT)
and the resulting epicardial-derived cells (EPDCs) contribute to the formation of coronary vessels.
Our previous data showed hypoxia inducible factor-1a (HIF-1a) expression at speciﬁc sites within the
epicardium and support a link between hypoxia inducible factors (HIFs) and the patterning of coronary
vasculogenesis. To better understand the autocrine role of HIFs in the epicardium, we transduced
adenovirus mediated expression of constitutively active HIF-1a (AdcaHIF1a) into the embryonic avian
epicardium where the vascular precursors reside. We found that introducing caHIF1a into the
epicardial mesothelium prevented EPDCs from proper migration into the myocardium. In vitro collagen
gel assays and ex vivo organ culture data further conﬁrmed that infection with AdcaHIF1a impaired the
ability of EPDCs to invade. However, the proﬁciency of epicardial cells to undergo EMT was enhanced
while the movement of EPDCs within the sub-epicardium and their differentiation into smooth muscle
cells were not disrupted by caHIF1a. We also showed that the transcript level of Flt-1 (VEGFR1), which
can act as a VEGF signaling inhibitor, increased several fold after introducing caHIF1a into epicardial
cells. Blocking the activation of the VEGF pathway in epicardial cells recapitulated the inhibition of
EPDC invasion. These results suggest that caHIF1a mediated up-regulation of Flt-1, which blocks the
activation of the VEGF pathway, is responsible for the inhibition of EPDC myocardial migration.
In conclusion, our studies demonstrate that HIF signaling potentially regulates the degree of epicardial
EMT and the extent of EPDC migration into the myocardium, both of which are likely critical in
patterning the coronary vasculature during early cardiac vasculogenesis. These signals could explain
why the larger coronaries appear and remain on the epicardial surface.
& 2013 Elsevier Inc. All rights reserved.Introduction
The epicardium is the last cardiac layer to emerge, arising from
the pro-epicardial serosa to form the outermost layer of the
heart. This tissue plays crucial roles during embryonic heart
development, especially in coronary vasculogenesis (Hiruma and
Hirakow, 1989; Mikawa and Fischman, 1992; Poelmann et al.,
1993; Viragh and Challice, 1981; Winter and Gittenberger-de
Groot, 2007). Concurrent with the formation of the epicardium, a
subset of epicardial cells undergoes epithelial–mesenchymal trans-
formation (EMT) and starts migration into the sub-epicardial
matrix. Some of these epicardial-derived cells (EPDCs) remain
within the sub-epicardium whereas a subpopulation migratesll rights reserved.
Diana Ranirez-Bergeron and
.farther into the compact zone of the myocardium. EPDCs have
the ability to differentiate and give rise to a variety of cell types,
including cellular elements of the coronary vasculature (Mikawa
and Fischman, 1992; Olivey et al., 2004; Poelmann et al., 1993;
Wessels and Perez-Pomares, 2004). In vivo and in vitro assays
reveal the functions of some important signals directing coronary
vessel formation, involving adhesion molecules, transcription fac-
tors and several growth factors (Lee et al., 2006; Morabito et al.,
2001; Olivey and Svensson, 2010). These factors, which are
important for epicardial EMT and further steps in coronary vessel
formation, could inherently originate from the epicardium and
EPDCs as well as from the myocardium (Olivey and Svensson,
2010). Although some elements involved in EMT and subsequent
steps in epicardial cell differentiation and migration have been
identiﬁed, the mechanisms that drive the speciﬁc spatial and
temporal pattern of coronary vasculogenesis are largely unknown.
It has been proposed that hypoxia triggers coronary vascular
development. A range of cellular responses to hypoxia is mediated
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constitutively expressed HIFb subunit and an oxygen sensitive HIFa
subunit (Wenger, 2002). To date, three HIFa genes and over 100 HIF
regulated genes have been identiﬁed (Wenger et al., 2005). Compo-
nents of the HIF complex have been described to be required for
normal development and patterning of the cardiovascular system
(Dunwoodie, 2009; Ramirez-Bergeron and Simon, 2001). Loss of
hypoxia inducible factor-1a (HIF-1a) in the mouse severely disrupts
myocardial and vascular endothelial development and embryos die
around E10 (Iyer et al., 1998; Ryan et al., 1998). It was also reported
that the absence of HIF-1b (ARNT) in mice results in abnormal cardiac
morphogenesis and embryonic lethality by E10 (Adelman et al., 2000;
Maltepe et al., 1997). Using the avian model, it was shown that
environmental oxygen inﬂuences embryonic angiogenesis and
hypoxia treatment causes myocardial and coronary artery anomalies
and an increase of capillary density in hypoxic regions (Nanka et al.,
2008). Our previous studies utilizing the hypoxia marker EF5 [2-(2-
nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3 pentaﬂuoropropyl)acetamide]
revealed the atrioventricular junction (AVJ), ventricular apex, and
interventricular septum (IVS) are relatively hypoxic in embryonic
hearts. Many of these regions corresponded to the sites where major
coronary vessels develop. Furthermore, hypoxia indicators and
nuclear labeling of HIF-1a were co-localized in these hypoxic regions
(Wikenheiser et al., 2006). Altered HIF-1a expression levels in the
myocardium disrupted normal patterning of coronary vessels, sug-
gesting that differential levels of hypoxia within the embryonic
myocardium modulate coronary vessel development through tran-
scriptional regulation by HIF-1 (Wikenheiser et al., 2009, in press).
Though the importance of myocardial HIF in regulating
coronary vasculogenesis has long been accepted, the functions
of epicardial-HIF during coronary vessel development have not
been studied (Tomanek et al., 2003). To unravel the in vivo roles of
epicardial-HIF signaling, we disturbed HIF-1a gene expression
and analyzed the consequences in ovo, in ex vivo explant culture,
and also in various in vitro systems. Here, we present evidence
that HIF-1 has a complex regulatory role during speciﬁc steps of
epicardial development. While EMT was stimulated by the forced
expression of constitutively active HIF-1a (caHIF1a), EPDCs
transduced with caHIF1a displayed profoundly impaired invasion
into and migration within the myocardium. Our ﬁndings support
the potential for micro-environmental hypoxia via HIFs and the
VEGF pathway to regulate both EMT and their ability to migrate
within the myocardium.Materials and methods
Chicken and quail fertilized eggs
Fertile White Leghorn chicken (Gallus gallus domesticus) eggs
were obtained from Case Western Reserve University’s Squire
Valleevue Farm (Cleveland, OH, USA) or from Charles River
(MA, USA). Fertile quail (Coturnix coturnix communis) eggs
were purchased from (Boyd’s Bird Company, Inc. Pullman, WA,
USA). Eggs were incubated in a humidiﬁed forced draft hatching
incubator (G.Q.F. Manufacturing Co., Savannah, GA, USA) at 38 1C
to the appropriate stages. The embryos were staged according to
the method of Hamburger and Hamilton (HH, Hamburger and
Hamilton, 1951).
In ovo injection of engineered adenoviruses into the pericardial space
and assessment of EPDC migration
Using a modiﬁcation of a previously described method (Fisher
et al., 1997; Fisher and Watanabe, 1996), 0.5 ml adenovirus
containing AdcaHIF1a or AdGFP (1109 pfu/ml) was injectedinto the pericardial space of the avian heart at stage HH 24 (ED 4),
when the surface of the heart is largely covered by the epicar-
dium. The AdcaHIF1a virus bears a constitutively active form
of human HIF-1a (caHIF1a) and green ﬂuorescent protein
(GFP) sequence which were driven by a dual CMV promoter
(Kelly et al., 2003). The caHIF1a contains a deletion of the oxygen-
dependent degradation domain (residues 392–520) and two
missense mutations (Pro567Thr and Pro658Gln). AdGFP contain-
ing the CMV promoter that drives expression of GFP was used as a
control. After injection, eggs were returned to the incubator and
embryos were harvested at stage HH26 (ED 5) and HH28 (ED 5.5–
6). GFP positive cells located in different regions and positions
were scored as follows. Comparable areas were randomly chosen
from non-serial sections for each group. The number of positive
cells containing distinct DAPI stained nuclei within these areas
were counted for each sample. At least 10 areas were scored for
each different region and the average number was determined by
the total number of positive cells divided by the total number of
areas counted in each of six independent experiments for each
stage (HH26 and HH28). DAPI positive cells at the AVJ were also
counted using the same method as described before.
Collagen gel assay and quantiﬁcation of migration
The collagen gel assay was performed as previously described
with some modiﬁcations (Dokic and Dettman, 2006). Brieﬂy,
neutralized collagen I gel was added to 24 well plates (700 ml/well)
and allowed to solidify at 37 1C in the incubator for 60 min. Stage
HH25 (ED 4.5) avian hearts were harvested in sterile PBS and placed
onto the surface of the gels which were covered by serum free M199
medium. After 24 h culturing at 37 1C, 5% CO2, hearts were removed
and epicardial monolayers were allowed to grow out on the surface
of the gel in serum free medium for 24 h. For virus infection
experiments, monolayers were incubated overnight with serum free
M199 containing AdGFP or AdcaHIF1a (1109 pfu/ml) and the
mediumwas then replaced with M199 supplemented with 10% fetal
bovine serum (FBS) or 10% FBSþ50 ng/ml VEGFA to trigger migra-
tion. After 36 h incubation, gels were ﬁxed in 4% paraformaldehyde
(PFA) in 1 PBS, washed and embedded in 1.5% agarose. Embedded
samples were equilibrated in 30% sucrose (w/v) overnight at 4 1C
and maintained at 80 1C. Cryosections (20 mm) were further
stained with DAPI and imaged on a Leica DM2500 microscope. For
inhibition experiments, epicardial monolayers were cultured in 10%
FBS M199 medium containing DMSO (Fisher Scientiﬁc, MA, USA),
DFO (150 mM, Sigma–Aldrich, MO, USA), SU5416 (15 mM, Calbio-
chem, CA, USA), MAZ51 (5 mM, EMD4 Biosciences, CA, USA), BSA
(30 mg/ml, Fisher), Fc-sFlt1 (30 mg/ml, R&D systems, MN, USA) for
2 days before analysis.
To evaluate cell migration, the Image J software (NIH) was
used to measure the distance for each GFP positive (for adeno-
virus experiments) or DAPI stained (for inhibition experiments)
cell that migrated from the surface into the gel. At least 15
comparable non-serial sections were chosen and analyzed for
each group per independent experiment. For each treatment
group, the average distance of migration was calculated by the
total distance of cell migration divided by the total number of
cells counted. Three independent experiments were performed
for each treatment.
Organ culture assay
For ex ovo migration assays, stage HH25 (ED 4.5) avian hearts
were excised from embryos in sterile PBS and cultured overnight
at 37 1C in serum free M199 medium added adenovirus (AdGFP or
AdcaHIF1a, 1109 pfu/ml). Then hearts were placed in fresh
M199 medium supplemented with 10% FBS and cultured for
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dissected stage HH25 hearts were placed in serum-free M199
mediumwith adenovirus (AdGFP, 1109 pfu/ml) and also control
[DMSO, BSA(30 mg/ml)], DFO (150 mM), or inhibitors [SU5416
(15 mM), MAZ51 (5 mM), Fc-sFlt1 (30 mg/ml)] and incubated at
37 1C overnight, then medium was replaced with 10% FBS M199
added the same control or inhibitors and hearts were continually
cultured for 1.5 days before ﬁxation and cutting.
Cell culture and adenovirus infection
For primary avian epicardial cell culture, stage HH25 (ED 4.5)
chicken or quail hearts were dissected and explanted into tissue
culture-treated dishes with M199 medium containing 10% FBS.
Hearts were removed after 24 h and the attached epicardial mono-
layers were allowed to grow in fresh medium. Immortalized cells
derived from E13.5 mouse hearts (Obtained from Dr. Barnett,
Vanderbilt University, USA) were propagated at 33 1C on collagen I
coated dishes in DMEM supplemented with 10% FBS, insulin–
transferrin–selenium (Invitrogen) and 10 units/ml mouse IFN-
gamma (Peprotech, NJ, USA) (Austin et al., 2008). Before starting the
next experiment, cells were transferred to DMEM medium without
ITS and IFN-g and with 5% FBS. To test the HIF-1a protein levels,
mouse epicardial cells were treated with DFO (150 mM) or incubated
under 1% O2 (Heracell 150 inbubators, Thermo scientiﬁc, IL, USA) for
2 h before harvest. Immortalized rat epicardial cells (Obtained from
Dr. Bader, Vanderbilt University, USA) were cultured in DMEM
medium supplemented with 10% FBS (Dokic and Dettman, 2006;
Eid et al., 1992). All cells were cultured at 37 1C in a 5% CO2 culture
incubator. Prior to infection, cells were washed with sterile PBS and
then incubated with serum free medium containing adenovirus
(AdGFP or AdcaHIF1a, 1109 pfu/ml) overnight at 37 1C. GFP expres-
sion in cells was monitored to determine the transfection efﬁciency.
Virus infected primary quail epicardial cells were incubated with
recombinant human TGFb1 (ﬁnal concentration 250 pM, Peprotech)
for 48 h to stimulate smooth muscle cell differentiation.
Immunohistochemistry
Dissected hearts or heart explants were ﬁxed in fresh 4% PFA
for 1 h at room temperature, then washed in 1PBS and
equilibrated in 30% sucrose overnight at 4 1C before embedding
in OCT. 10 mm thick sections were collected on treated slides
(Plus, Fisher) and immunostained with antibodies. For HIF-1a and
VEGFA staining, primary antibody was detected with goat anti-
rabbit IgG secondary antibody conjugated with biotin (Vector,
Burlingame, CA) at 1:400 (HIF-1a) or 1: 100 (VEGFA) dilution, and
the signal was ampliﬁed with the TSA systems with ﬂuorescein
tyramide signal (Perkin Elmer, Boston, MA) (HIF-1a) or DAB
system (Vector) (VEGFA). VEGFA staining was quantiﬁed using
Image J software. Cells were washed in PBS and ﬁxed with 4% PFA
for 10 min at room temperature, then washed in PBS and
permeabilized with 0.2% Triton X-100 for 5 min. After blocking
with 2% bovine serum albumin in PBS for 1 h, cells were
incubated with diluted primary antibodies overnight at 4 1C and
detected with appropriate secondary antibodies.
The following antibodies were used: anti-ZO1 antibody (1:100,
Invitrogen), anti-b catenin antibody (1:50, Cell Signaling, MA,
USA), anti-HIF-1a (1:600, gift of Dr. Faton Agani), anti-PH3 anti-
body (1:100, Cell Signaling), anti-VEGFA antibody (1:50, Neomar-
kers, MI, USA), anti-SM22a antibody (1:200, Abcam, MA, USA),
anti-a smooth muscle actin conjugated with Cy3 (1:200, Sigma–
Aldrich, MO, USA). MF-20 antibody (1:50) were obtained from the
Developmental Studies Hybridoma Bank created under the aus-
pices of the NICHD and maintained by the University of Iowa
Department of Biology, Iowa City, IA 522422. Texas Red-phalloidin(1:40, Invitrogen) was used to label F-actin to delineate the cellular
cytoskeleton. Terminal deoxynucleotidyltransferase (TdT) analysis
(TUNEL) was carried out on frozen sections or ﬁxed cells and
developed with DAB according to the manufacturer’s protocol (In
situ cell death detection kit, Roche, IN, USA). Photomicrographs were
captured with an inverted ﬂuorescence microscope (Leica DM2500)
and QCapture Pro software.
For quantiﬁcation of cell numbers, comparable areas were
randomly chosen from each group and numbers of positive cells
were counted. At least 6 areas were scored for each sample.Western blotting
Proteins were quantiﬁed using a Bradford assay (Pierce Bio-
tech, IL, USA) and equal amounts were loaded onto 10% SDS-PAGE
gels (Bio-Rad, CA, USA) and transferred to a PVDF membrane
(Millipore, MA, USA). Membranes were blocked for 1 h at room
temperature followed by incubation with primary antibodies
overnight at 4 1C. The following antibodies were used: anti-b
actin (1:10,0000, Sigma), anti-E-cadherin (1:1000, BD Biosciences,
CA, USA), anti-HIF-1a (1:500, Novus, CO, USA). Then the blots
were incubated with appropriate secondary anbibodies for 1 h at
room temperature. Signals were then visualized with a HRP
detection kit (Pierce).Real time RT-PCR
Total RNA was isolated from cultured avian epicardial cells using
the RNeasy mini kit (Qiagen, CA, USA) and 1 mg of total RNA was used
for cDNA synthesis with the iscriptcDNA synthesis kit (Bio-Rad)
according to the manufacturer’s instructions. Real-time PCR was
performed using SYBR (SYBR supermix, Bio-Rad). 18S was used as


















Adenovirus infected primary quail epicardial cells were
starved in serum free medium for 18 h and seeded at a density
of 1104 cells/well onto the upper insert (non-coated) of the
transwell chamber (Corning, MA, USA). The bottom chamber was
ﬁlled with M199 medium (700 ml/well) supplemented with 10%
FBS or growth factors: VEGFA (15 ng/ml, Invitrogen) or TGFb1
J. Tao et al. / Developmental Biology 376 (2013) 136–149 139(5 ng/ml) as the chemical attractant. Cells were permitted to
migrate for 12 h. Then the non-migrated cells on the upper side
were removed carefully with a cotton swab and the ﬁlters were
ﬁxed with 4% PFA before staining with DAPI solution. Migrated
cells were counted in ﬁve randomly chosen ﬁelds under ﬂuor-
escent microscope at 100 magniﬁcation. Three independent
experiments were performed for each treatment.
Statistical analysis
Data are presented as means7SEM. All Statistical analysis was
performed using student’s paired t test. P valueo0.05 was considered
signiﬁcant.Results
Expression of constitutively active HIF-1a in the epicardium inhibits
EPDC migration into the myocardium
During avian embryo development, the heart is largely covered
by epicardial cells by stage HH24 (Hiruma and Hirakow, 1989).Fig. 1. HIF-1a expression in the epicardium and subepicardium. Costaining for HIF-1a
and subepicardium during stage HH24-28. HIF-1a expression was observed in a few ven
especially intense in the epicardium and subepicardium at the AVJ at stage HH26 (E–H)
also detected in myocardial cells (E–P). Dashed lines delineate the border between the
epicardial or subepicardial cells and arrowheads point to HIF-1a positive myocardial cEndogenous HIF-1a expression in the epicardium and subepicardium
from stage HH24 to stage HH28 was examined by immunoﬂuores-
cence staining (Figs. 1, S7). Few ventricular epicardial or sub-
epicardial cells were HIF-1a positive at stage HH24 to stage HH28
(Fig. 1A–D and M–P). Most of the HIF-1a positive staining in the
epicardium or subepicardium was concentrated at the atrioventricu-
lar junction (AVJ) at these stages (Fig. 1E–L). Besides the staining in
the epicardium and subepicardium, an increase of the number of HIF-
1a positive nuclei in the myocardium was also observed during
stages 26–28 (Fig. 1E–P). In order to investigate the intrinsic role of
epicardial HIF-1 during EMT and subsequent EPDC migration in vivo,
we utilized a replication defective adenovirus carrying a mutated
form of HIF-1a that eliminates key regulatory oxygen-sensitive
sites inhibiting protein turnover and rendering it constitutively active
(caHIF1a) (Kelly et al., 2003). We injected the caHIF1a co-expressing
a GFP reporter gene or the gene for GFP alone (negative control) into
the pericardial space of avian embryos at stage HH24. This injection
strategy ensured that the epicardium, but not the underlying myo-
cardium was infected. We were able to determine whether the gain
of function of HIF-1a (caHIF1a) had an effect on EPDC migration by
comparing the location in histological sections of AdcaHIF1a- and the
AdGFP-infected cells; both sets of infected cells expressed the GFP tag.and the myocardium marker MF20 reveals the HIF-1a staining in the epicardium
tricular epicardial cells at stage HH24 (A–D) and stage HH28 (M–P). (E–L) HIF-1a is
and continued to be nuclear-localized in this area to stage HH28 (I–L). HIF-1a was
myocardium and the epicardium/subepicardium. Arrows point to HIF-1a positive
ells. Bar¼20 mm for A–H and M–P, Bar¼40 mm for I–L.
Fig. 2. Few EPDCs expressing constitutively active HIF-1a were found in the myocardium after in ovo transfection. Sections of virally transfected embryonic quail (A–D) or
chicken (E, F) hearts were stained with anti-MF20 (red) antibody to label myocardium. Many labeled EPDCs were found in the myocardium of control AdGFP transfected
hearts (A, C, E), while only a few AdcaHIF1a-infected cells (green) were detected in the myocardium (B, D, F). Arrows point to GFPþEPDCs. At: atrium; AVJ: atrioventricular
junction; LV: left ventricle; RV: right ventricle; epi: epicardium; myo: myocardium. Bar¼100 mm for A and B and 25 mm for C–F. (G) GFPþ cell numbers detected in the
myocardium of control AdGFP- and AdcaHIF1a-infected hearts, n¼6. *Po0.05; **Po0.01.
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reduced numbers of cells expressing the GFP marker within the
myocardium (Fig. 2). In quails this defect was ﬁrst identiﬁed at stage
HH26 (Fig. 2A and B), and became more obvious at later stages
(Fig. 2C and D). A similar deﬁciency of GFPþ cell numbers in the
myocardium was also detected in another avian species, chicken
embryos, injected with caHIF1a (Fig. 2E and F). GFPþ cells were
quantiﬁed in comparable areas within the myocardium of
AdcaHIF1a- and AdGFP-infected quail embryos at various develop-
mental stages. We discovered that the most signiﬁcant decrease in
the number of EPDCs infected with AdcaHIF1a occurred in the
ventricular myocardium (Po0.01, Fig. 2G). This reduction was less
prominent in the atrial myocardium than in the myocardium of the
ventricle and at the AVJ (Fig. 2G).Fig. 3. In vitro experiments demonstrated that expression of HIF-1a inhibited the inv
hearts, penetration into the myocardium was signiﬁcantly deeper for EPDCs with the con
(D) Quantitative data show the number of GFPþ EPDCs in ventricular myocardium signiﬁc
control. EPDCs were marked by GFP (green) and the depth reached by EPDCs is indicated
containing adenovirus infected (E, F) or DFO treated (H, I) epicardial cell monolayers (from s
the gel, arrow indicates the direction of invasion by the epicardial cells into the collagen ge
H and I; (G) Quantiﬁcation of the average distance of virus infected quail EPDC migration in
treated with DMSO control or HIF-1a inducer DFO (48 h, n¼3). (K) Western blotting result
infected with AdcaHIF1a. Actin was used as the loading control.We further performed an ex vivo assay to examine whether we
can observe similar defects in this more accessible system where
the viral infection was more consistent. Quail hearts were
dissected and infected with adenovirus in vitro, then processed
for immunohistochemistry. The results conﬁrmed that AdcaHIF1a
greatly inhibited the migration of EPDCs into the myocardium in
this ex vivo environment (Fig. 3A, B and D). Furthermore, we
observed similar inhibition of EPDC migration in cultured hearts
treated with desferrioxamine (DFO), a hypoxia-mimetic agent
that induces HIF-1a protein (Fig. 3C and D). This defect was also
reproduced in AdcaHIF1a infected chicken embryo heart explants
cultures (data not shown).
To test the intrinsic biological effects of caHIF1a epicardial
cells devoid of inﬂuences from other types of cells which exist inasion of epicardial cell derivatives. (A–D) In the heart explant culture using quail
trol AdGFP (A) than those infected with the AdcaHIF1a (B) or treated with DFO (C);
antly decreased in AdcaHIF1a infected or DFO treated group compared to the AdGFP
by dashed lines. Scale bar represents 25 mm for A–C. (E–J) Sections of collagen gels
tage HH25 quail hearts) were stained with DAPI. Dashed lines delineate the surface of
l and arrowheads point to the migrated cells without GFP. Bar¼20 mm for E and F and
to gels (48 h, n¼3); (J) Quantiﬁcation of the average migration distance of quail EPDC
showing HIF-1a protein levels in mouse epicardial cells treated with hypoxia, DFO or
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Epicardial monolayers derived from stage HH25 quail hearts were
cultured on collagen gels and infected with adenovirus. GFP was
used to track epicardial cell invasion into the matrix. GFPþ cells
from AdGFP-infected control cultures were found to penetrate
deep into the gel (Fig. 3E). In contrast, GFPþ cells from AdcaHIF1a
infected cultures failed to inﬁltrate the collagen gel (Fig. 3F).
Importantly, we observed that uninfected GFP-cells detected by
DAPI staining were able to migrate extensively even in the
presence of AdcaHIF1a infected cells (arrowheads, Fig. 3F), indi-
cating that the inhibition was cell autonomous. Measurements of
the distances traveled by GFPþ EPDCs in the collagen gels
demonstrated a statistically signiﬁcant decrease (about 60%,
35.475.6 mm for AdGFP-infected cells and 16.475.5 mm for
AdcaHIF1a control) in the invasion of AdcaHIF1a infected cells
(Po0.01, Fig. 2G). Furthermore, monolayers treated with DFO
also exhibited impaired invasion of epicardial cells with cell
migration distances signiﬁcantly decreased by 50% (Po0.05,
Fig. 3H–J). Western blot of mouse epicardial cell lysates indicated
that AdcaHIF1a infection and the DFO are effective methods
mimicking the hypoxic condition by inducing the accumulation
of HIF-1a protein (Fig. 3K). These ex ovo and in vitro data closely
mirrored our in ovo experiments and strongly indicate that
over-expression of stable HIF-1a in the epicardium impairs the
ability of epicardial-derived cells to travel a distance into matrices
in a complex active or inactive myocardium or in a simple
collagen gel.
Forced expression of HIF-1a does not affect cell proliferation and
survival but stimulates epithelial–mesenchymal transformation
There are many potential explanations for fewer AdcaHIF1a
infected cells in the myocardium compared to AdGFP cells.
AdcaHIF1a infected cells (1) cannot proliferate or survive before
they migrate, (2) are unable to migrate at all, (3) are not capable
of undergoing EMT, (4) fail to respond to extrinsic signals, and/or
(5) may undergo EMT and travel within the epicardial matrix but
are incapable of migrating to and/or within the myocardium.
The total number of cells in the epicardium and subepicardium
at the AVJ was evaluated by DAPI staining and no obvious
difference was detected between the control and AdcaHIF1a
group, suggesting that cell proliferation and survival are not
inﬂuenced by AdcaHIF1a infection (Fig. 4A). To further determine
whether the reduction in number of AdcaHIF1aGFPþ cells within
the myocardium resulted from reduced cell proliferation of
epicardial cells or EPDCs, quail heart sections were stained with
an anti-phosphohistone H3 (PH-3), a sensitive marker for mitosis.
There was no signiﬁcant difference in the number of PH-3 positive
cells in the epicardium infected with either AdGFP or AdcaHIF1a
(Figs. S1A, E and I). Likewise, the data showed no signiﬁcant
difference in TUNELþ immunostained apoptotic cell numbers
between the AdGFP and AdcaHIF1a infected hearts (Figs. S1B, F
and I). Furthermore, in vitro cultured quail epicardial cells
displayed no alteration of proliferation or survival in AdcaHIF1a
transfected cells (Figs. S1C, D, G, H and J). According to these
results, changes in cell proliferation and survival could not
explain the reduced numbers of HIF-1a transduced EPDCs within
the myocardium.
Based on our immunostaining data, EPDC movement into the
connective tissue of the subepicardium was grossly normal
despite the fact that their migration into and within the myocar-
dium was inhibited. In both AdcaHIF1a and control AdGFP-
infected quail hearts, GFPþ cells were detected populating the
width of the subepicardial space of the AVJ region even where the
epicardium is especially thick (maximal thickness is around
75 mm, Fig. 4B, C). There were no signiﬁcant differences inthe number of EPDCs in the subepicardium of the AVJ between
the control AdGFP and the AdcaHIF1a transduced hearts (Fig. 4D).
While evaluation of GFPþ cell migration within the subepicar-
dium covering the ventricle and atrium was difﬁcult due to the
thinner epicardium than at the AVJ, no discernable gross differ-
ences were observed. To examine the intrinsic motility of
AdcaHIF1a cells, we utilized a Transwell assay thus eliminating
matrix invasion requirements and exclusively assayed their
response to growth factor stimuli. Infected primary cultures of
quail epicardial cells were seeded onto the un-coated top cham-
bers and exposed for 12 h to the medium in the lower wells
containing FBS, vascular endothelial growth factor A (VEGFA,
15 ng/ml) or transforming growth factor beta-1 (TGF-b1, 5 ng/ml)
(Han et al., 2012; Kim et al., 2006). Cells that migrated through the
pores of the ﬁlter to the underside were microscopically quantiﬁed.
There was no signiﬁcant difference in the number of migrated cells
in the AdGFP and AdcaHIF1a cultures, suggesting that the expres-
sion of caHIF1a had no inﬂuence on the initial chemotactic
responses of the epicardial cell, that is, their ability to release and
migrate a limited distance in the direction of the source of the
growth factors (Fig. 4E).
As epicardial precursors contribute to the coronary vascula-
ture, EPDCs need to undergo EMT to acquire the ability to migrate.
Unchanged EPDC invasion into and within the subepicardium and
responses to growth factor stimuli directed us to postulate that
epicardial EMT was not disrupted due to the expression of
caHIF1a. To test this hypothesis, quail epicardial monolayers
from stage HH25 hearts were cultured and transfected with
AdGFP and AdcaHIF1a. Since loss of cell–cell adhesion is an
important early step in epicardial EMT, we stained the cells with
an antibody to zonula occludens-1 (ZO-1), a marker for tight
junctions that directly interact with the actin cytoskeleton.
Primary epicardial cells infected with AdcaHIF1a lost strong
immunostaining for ZO-1 at cell–cell borders when compared to
the AdGFP-infected cells (Figs. 5A–F). This feature was replicated
in chicken epicardial cell cultures (data not shown). Moreover, we
detected a decreased expression of ZO-1 and elongation of cell
shape in immortalized mouse embryonic epicardial cells infected
with AdcaHIF1a (Figs. S2A–F). Phalloidin staining further indi-
cated that stress ﬁbers were increased in cells with forced
expression of caHIF1a when compared to controls (Figs. S2G–L).
In the rat adult epicardial cell culture system, we further observed
an even distribution of b-catenin at cell membranes at cell–cell
junctions in AdGFP-infected control cells (Fig. S3A–C), whereas
robust staining was detected in the cytoplasm in cells expressing
caHIF1a (Fig. S3D–F). These ﬁndings suggest that forced expres-
sion of caHIF1a results in the altered expression and distribution
of proteins important in cell–cell connections, a characteristic of
cells undergoing EMT.
Previous studies supported that EMT is accompanied by
enhanced expression of twist and a decrease of E-cadherin, while
integrin a4 is reported to be an inhibitor of EMT (Dettman et al.,
2003; Lee et al., 2006). We further examined the transcript
levels of some important EMT markers in primary chicken
epicardial monolayer cultures by quantitative real-time PCR.
In AdcaHIF1a infected cells, there were statistically signiﬁcant
changes in the expression levels of a subset of EMT markers
including the increased expression of twist2 and reduced levels
of integrin a4 and b1 transcripts, as compared to the AdGFP
controls (Fig. 5G). No signiﬁcant changes were observed in the
expression of twist1 and vimentin. Furthermore, E-cadherin
protein levels were decreased in rat adult epicardial cells
transfected with AdcaHIF1a (Fig. S3G). The alteration of the
tested EMT markers is consistent with the loss of epithelial
characteristics detected from immunostaining experiments,
indicating that expression of caHIF1a in epicardial cells
Fig. 4. EPDCs infected with AdcaHIF1a invaded the subepicardium. Cell migration into and within the sub-epicardium was not affected even within the thick
subepicardium at the AVJ (A–C). (A) Total cell numbers in the epicardium and subepicardium at the AVJ counted in DAPI stained sections were not signiﬁcantly different
between control and AdcaHIF1a infected hearts. (B, C) GFP positive cells were found in the thick sub-epicardium of the AVJ both in AdGFP and AdcaHIF1a infected quail
hearts with no obvious differences in numbers or location. epi: epicardium; se: sub-epicardium. Bar¼25 mm for B and C. (D) Quantitative analysis indicated that the
number of AdcaHIF1a infected cells located in the sub-epicardium of the AVJ was not signiﬁcantly different from the number of AdGFP-infected cells assayed at two stages,
n¼6. (E) Transwell experiments demonstrated that the initial response to growth factor stimuli, the release from neighboring epicardial cells and the short migration
through the 8 mm pore through the 10 mm thick Transwell membrane, was not altered in epicardial cells with caHIF1a. SFM: serum free medium.
J. Tao et al. / Developmental Biology 376 (2013) 136–149 143promotes EMT. Therefore because EMT itself is not inhibited but
in fact enhanced, the defective invasion/migration of HIF-1a
transduced epicardial cells may be due to changes that inhibit
cells from migrating substantial distances into and interacting
with substrates after they undergo EMT.Differentiation of EPDCs into smooth muscle cells was not affected
in cells infected with AdcaHIF1a
Another point to consider while investigating the role of HIF-1
in regulating the commitment of EPDC to coronary vasculogenesis
Fig. 5. caHIF1a expression promotes characteristics of EMT in epicardial cells. (A–F) Loss of tight junctions in AdcaHIF1a treated primary quail epicardial cells. Quail
monolayers derived from stage HH25 hearts were incubated with AdGFP (A–C) or AdcaHIF1a (D–F) and ﬁxed for examination of ZO-1 (red) immunostaining. AdcaHIF1a
infected cells displayed loss of cell-cell contacts and ZO-1 expression at cell-cell borders (E, F). Scale bar represents 30 mm for A–F. (G) Quantitative RT-PCR analysis of
expression of some EMT associated markers in chicken epicardial cells transfected with AdGFP and AdcaHIF1a. *P o0.05; **P o0.01.
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We utilized an in vitro culture system to address whether EPDCs
with caHIF1a can give rise to vascular smooth muscle cells
(VSMCs). It has been shown that TGFb1 triggers epicardial EMT
and the differentiation of epicardial cells into VSMCs (Austin
et al., 2008; Olivey et al., 2006). Here, quail monolayers were
treated with TGFb1 for 48 h and then analyzed for differentiation
into VSMCs by staining with two different markers: anti-smooth
muscle actin (SMA) and SM22a. Expression of SMA or SM22a was
observed in both AdGFP and AdcaHIF1a infected cells in response
to TGFb1 (Figs. 6A–F, S4A–F), suggesting that forced expression
of caHIF1a did not disrupt the differentiation of EPDCs into
VSMCs. Quantiﬁcation further conﬁrmed no signiﬁcant difference
between AdGFP and AdcaHIF1a groups in terms of the percent ofSMAþGFPþ cells (Figs. 6G and S4G). In summary, caHIF1a
expression in epicardial cells had no effect on EPDC differentia-
tion into vascular smooth muscle cells.
The up-regulation of Flt-1 in epicardial cells expressing constitutively
active HIF-1a contributes to their altered migration
Many of the pathways that are involved in epicardial EMT
and in directing EPDC migration and differentiation are activated
by growth factors, including VEGF (Olivey and Svensson, 2010).
VEGFA and vascular endothelial growth factor receptor 1
(VEGFR1, Flt-1) are known HIF-1 target genes (Forsythe et al.,
1996; Gerber et al., 1997; Wenger et al., 2005). We used
quantitative real time RT-PCR to examine the expression levels
Fig. 6. EPDC differentiation into smooth muscle cells was not disrupted by expression of caHIF1a. (A–F) TGFb1 (250 pM) induced SMA expression (red) in stress ﬁbers in both
AdGFP (A–C) and AdcaHIF1a treated quail epicardial cells (D–F). Scale bar represents 30 mm for A–F. (G) Quantiﬁcation of the percent of SMA GFP positive cells in total GFPþ cells.
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epicardial cells with caHIF1a expression. We found that cells
infected with AdcaHIF1a expressed 3.7 fold more Flt-1 transcript
levels than those infected with the control AdGFP (Fig. 7A).
By contrast, transcript levels of Flk-1 did not increase signiﬁ-
cantly (Fig. 7A). VegfA expression was also up-regulated,
although modestly (1.5-fold, Po0.05) (Fig. 7A). Immunohisto-
chemical analysis further conﬁrmed that VEGFA protein levels
were not markedly increased nor were patterns of expression
changed by AdcaHIF1a (Fig. S5A–C). Primary cultures of quail
epicardial cells demonstrated the same expression pattern for
these transcripts as the chicken epicardial cells (Fig. S5D). Given
that Flk-1 mediates most of the responses to VEGF and the
soluble form of Flt-1 acts as a decoy receptor that sequesters
VEGF from Flk-1 (Shibuya, 2006), the above data imply that the
up-regulation of Flt-1 is a possible underlying mechanism
associated with the aberrant EPDC migration within the
myocardium. On this basis, we proposed that the increased
expression of Flt-1 induced by AdcaHIF1a negatively regulated
the VEGF intracellular signaling mediated by Flk-1, which
resulted in the impaired invasion of EPDCs into and within the
myocardium.To test our hypothesis, we used the collagen gel assay to
examine the in vitro migration of EPDCs in the presence of
inhibitors for the VEGF signaling pathway. Chicken epicardial
cells were cultured in 10% FBS medium with or without VEGF
signaling pathway inhibitors. FBS signiﬁcantly stimulated epicar-
dial cell invasion into collagen gels in the DMSO vehicle control
(Fig. 7B). In contrast, when monolayers were treated with a
speciﬁc intrinsic inhibitor (SU5416) of Flk-1 tyrosine kinase
activity, the migration of cells was strongly reduced (Fig. 7C).
The average distance traveled from the surface by cells treated
with SU5416 was 35% that of the DMSO control group (Fig. 7L).
The recombinant soluble Fc-sFlt1 chimera was utilized to block
extrinsic VEGF signaling by trapping VEGF and further preventing
its binding and activation of cellular receptors (Ambati et al.,
2006; Roberts et al., 2004). We observed that addition of Fc-sFlt1
inhibited the EPDC invasion stimulated by FBS (Fig. 7E and F).
Although the effect was not as robust as with SU5416, the migration
distance was signiﬁcantly diminished (by 40%) (Fig. 7L). MAZ51, an
inhibitor speciﬁc for VEGFR3 when used at low concentration had
no impact on the cell invasion triggered by FBS (Fig. 7B and D),
suggesting that the inhibition was speciﬁcally taking effect through
signaling pathways mediated by VEGF:Flk-1/Flt-1.
Fig. 7. Increased levels of Flt-1 that inhibits Flk-1 signaling could be the mechanism for the inhibition of EPDC migration into the myocardium. (A) Expression of important
factors involved in the VEGF signaling pathway was evaluated using qRT-PCR analysis in chicken epicardial cells, n¼3. The level of Flt-1 mRNA expression was much
higher in AdcaHIF1a transfected cells compared with the AdGFP transfected cells. (B–K) Data from in vitro collagen gel assays (B–F) or heart explant cultures (G–K) showed
that chicken epicardial cells invaded efﬁciently in the vehicle control DMSO (B, G), with the BSA alone control (E, J), and even with the addition of the VEGFR3 speciﬁc
inhibitor MAZ51 (D, I). In contrast, the invasion of epicardial cells into gels or the myocardium was inhibited by the Flk-1 speciﬁc inhibitor SU5416 (C, H), or Fc-sFlt1 which
was utilized to trap VEGF ligands (F, K). Treatments are indicated at the top of the panel. Scale bars represent 20 mm for B–F and 25 mm for G–K. (L) Quantiﬁcation of
average migration distances of epicardial cells in collagen gel assay (Normalized to comparable control group: DMSO or BSA group). (M) Collagen gel assay indicated that
inhibition of EPDC migration was partially rescued by VEGFA (50 ng/ml) treatment.
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whole heart explant culture system was used to test the effect of
VEGF inhibitors on EPDC migration in the myocardium. The resultsdemonstrated that SU5416 (Fig. 7H) and Fc-sFlt1 (Fig. 7K) treat-
ment blocked the EPDC invasion into the myocardium when
compared to DMSO (Fig. 7G) and BSA (Fig. 7J) control groups.
J. Tao et al. / Developmental Biology 376 (2013) 136–149 147Moreover, we again did not identify any inhibition of migration in
the MAZ51-treated hearts (Fig. 7I). The collagen gel system was
further used to examine whether VEGFA can rescue the inhibition
of cell invasion. Evaluation of the migration distance clearly
indicated that the average migration distance signiﬁcantly
increased in VEGFA treated AdcaHIF1aGFPþ cells compared to
the AdcaHIF1a control cells (Figs. 7M, S6). Together these data
support the hypothesis that enhanced expression of Flt-1 in EPDCs
as a result of expressing caHIF1a inhibited cell invasion into and
within the myocardium via the inhibition of the VEGF pathway.Discussion
HIF regulates EPDC invasion
Although previous studies provide some clues about the reg-
ulatory system that drives EPDC invasion, the mechanisms that
spatio-temporally regulate EPDC migration to their ﬁnal destina-
tion have not been deﬁned. In this study, we present evidence thatFig. 8. Model of how hypoxia regulates EPDC invasion into the ventricular myocardium.
stage (stage HH24) and its expression in the myocardium increases at later stages (i.e.
myocardium. However, disruption of the normal pattern of HIF expression with a susta
up-regulation of expression of Flt-1 (possibly for both membrane and soluble forms),HIF-1 regulates EPDC invasion and hypoxia is a potential guiding
signal required for proper coronary vessel formation (Fig. 8). Our
immunostaining data and previous studies support that during
heart development, differential levels of hypoxia exist in speciﬁc
regions thereby establishing a dynamic process for moderating the
levels of HIF-1a expression in the epicardium and myocardium
that coordinate the transcriptional regulation of multiple target
genes essential for proper cardiac development, including EPDCs’
proﬁciency to form coronary vessels. At the stages we investigated,
HIF-1a expression in the epicardium and subepicardium is always
high at the AVJ but lower on the ventricle. However, its expression
in the myocardium increases during heart development. Indeed, a
current hypothesis is that the local hypoxic microenvironment
inﬂuences the maintenance and differentiation of both embryonic
and adult stem cells (Mohyeldin et al., 2010; Simon and Keith,
2008). We postulate that by affecting the normal dynamic expres-
sion of HIF-1 protein in AdcaHIF1a infected embryonic epicardium,
the inability to moderate the temporal-spatial expression of HIF-1
exacerbates intrinsic signals that promote the proper migration of
EPDCs (Fig. 8).In AdGFP-injected controls, HIF-1a is expressed in some epicardial cells at an early
, stage HH28). This pattern guides EPDC invasion through the subepicardium and
ined expression in the epicardium mediated by adenovirus caHIF1a results in the
which leads to the inhibition of EPDC migration into the myocardium.
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species with four-chambered hearts. However, coronary anoma-
lies associated with negative consequences for morbidity and
mortality do occur (Frommelt and Frommelt, 2004; Jureidini
et al., 1998; von Ludinghausen, 2003). The underlying mechan-
isms for coronary anomalies arising during cardiogenesis have not
been understood. Here, we indicate that HIF-1 is crucial for
regulating epicardial EMT and also regulates the invasion of the
progenitor cells of vessels into the myocardium. Very hypoxic
sulcus regions, as detected by hypoxia indicators and nuclear-
localized HIF1a, are also the regions where major coronary vessels
develop (Mancini et al., 1991; Nanka et al., 2006; Wikenheiser
et al., 2009). Such major coronary vessels are generally found
within the epicardium at sulcus regions but in rare conditions,
such as myocardial bridging, a segment of a major coronary vessel
can dive into the myocardium (Loukas et al., 2011). Our ﬁndings
provide a potential explanation for why the major coronary
vessels usually stay within the epicardium. The sulcus regions
in the embryonic heart would have more HIF-1 positive epicardial
cells than other regions. Thus these cells would undergo EMT
more readily and be inhibited from migrating into the myocar-
dium. This would result in a dense population of precursor cells
within the epicardium at sulcus regions that would be available
for differentiation and incorporation into large vessels. In other
epicardial regions of the heart, EMT would occur later but without
the high levels of HIF-1 in epicardial cells, the precursors would
be able to travel substantial distances into the myocardium. In
this scenario, the level of epicardial HIF would control the location
of large, medium and small vessels within the myocardial wall by
controlling the depth reached by progenitor cells.
The VEGF signaling pathway and EPDC migration in the myocardium
Our ﬁndings support that caHIF1a inhibits EPDC invasion
through the disruption of the VEGF signaling pathway. VEGF
binds to tyrosine kinase receptors and plays a major role in
vasculogenesis and angiogenesis (Shibuya, 2006). It has been
recognized that expression of some crucial components of the
VEGF pathway are regulated by hypoxia (Elvert et al., 2003;
Forsythe et al., 1996; Gerber et al., 1997; Han et al., 2010).
Investigating the relationship between hypoxia, VEGF, and the
development of coronary vasculature reveals that vascular
growth is accelerated in heart explants incubated under hypoxic
conditions, accompanied by the up-regulation of VegfA mRNA
(Yue and Tomanek, 1999). In ovo injection of VEGF-Trap or soluble
VEGFRs precludes or reduces the formation of coronary arteries
(Tomanek et al., 2006). In addition, in vitro treatment with
VEGF164 increases epicardial EMT whereas blocking the VEGF
signaling pathway via Flk-1 speciﬁc inhibitor decreases endothe-
lial tube formation (Nesbitt et al., 2009). These published studies
further support a critical correlation among HIF, VEGF and
coronary vasculogenesis.
Our data document that forced expression of caHIF1a in
epicardial cells increased the expression of Flt-1 transcripts.
Although some controversy exists, Flk-1 and Flt-1 are considered
positive and negative regulators of VEGF signaling, respectively
(Shibuya, 2006). While membrane bound Flt-1 possesses higher
afﬁnity for VEGFA than Flk-1, it has relatively weak tyrosine
kinase activity (De Vries et al., 1992). In its soluble form, sFlt1,
competes with Flk-1 by binding to VEGFA and can be considered
to be of great importance in generating a VEGF gradient. Indeed,
levels of VEGF signaling are well documented in controlling
sprouting of endothelial cells (Chappell et al., 2009; Han et al.,
2010; Kappas et al., 2008). In our study, blocking VEGF signaling
using either cell intrinsic or extrinsic inhibitors resulted in
inhibition of EPDC migration similar to that observed whenepicardial cells were transduced with caHIF1a. These results
indicate that VEGF signaling is required for EPDC movement
within the myocardium and caHIF1a inhibits this process by
elevating the levels of Flt-1.
Distinct roles of VEGF signaling during valve development
have been described in a transgenic mouse study indicating that
Flt-1 is required for endocardial cell EMT in the outﬂow tract
(OFT) while Flk-1 plays a role in morphogenesis of atrioventri-
cular canal (AVC) cushions (Stankunas et al., 2010). Another
signiﬁcant ﬁnding in human fetal hearts shows that endothelial
cells lining epicardial coronary arteries exclusively express Flt-1
but those lining myocardial capillaries express both Flt-1 and
Flk-1 (Partanen et al., 1999). While Flt-1 have been shown to be
HIF-1a and HIF-2a transcriptional targets, Flk-1 is considered to
be only a HIF-2 target (Elvert et al., 2003; Kappel et al., 1999).
Considering these data, we propose HIF-1 and HIF-2 may have
distinct roles in regulating the spatiotemporal levels of Flt-1 and
Flk-1 and the intrinsic Flt-1:Flk-1 ratio strongly inﬂuences the
ﬁnal location of EPDCs and their derivatives within the depth of
the heart wall.
Although myocardially expressed VEGF has been recognized to
potently stimulate epicardial EMT and further induce coronary
vessel formation by a paracrine process (Tomanek et al., 2006),
we believe this to be the ﬁrst report supporting that cell
autonomous VEGF signaling is involved in regulating EPDC inva-
sion of the myocardium. It is valuable to further unravel the
downstream factors associated with the VEGF pathway whose
function is indispensable for proper EPDC migration into the
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